跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFEPIME FOR INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CEFEPIME FOR INJECTION USP
Authorized
STANDARD
CEFEPIME FOR INJECTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e0345141468fe785
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
e0345141468fe785
Drug Approval Canada Name
CEFEPIME FOR INJECTION USP
Product Name
CEFEPIME FOR INJECTION USP
Status
Marketed
Status Date
2022-05-25
Original Market Date
2021-07-09
Din
02499096
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.06.16
Atc Original
J01DE01 CEFEPIME
Atc Name
j 01 de 01
Aig Number
0150504005
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
CEFEPIME (CEFEPIME HYDROCHLORIDE)
2 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e0345141468fe785
Type
Standard
Back to Health Canada Approvals